Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Ifigeneia Tzannou, MD

Baylor College of Medicine, Texas Children’s Hospital

Disclosure(s): AlloVir: Advisor/Consultant

Poster(s):

2161 - Posoleucel, an Allogeneic, Off-the-Shelf Multi-Virus Specific T Cell Therapy, for Severe, Drug-Refractory Viral Infections in Pediatric Patients Following HCT: Results from a Phase 2 Trial
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET